Plant-Based Biopharmaceuticals represent an innovative frontier in biotechnology, leveraging plants as biofactories for the production of therapeutic proteins and pharmaceuticals. This approach involves genetically engineering plants to express specific genes that encode for therapeutic proteins, enabling cost-effective and scalable production. It has the ability to produce complex proteins in a plant-based system, offering a flexible and sustainable alternative to traditional expression platforms. Plants such as tobacco, potatoes, and tomatoes are commonly used for this purpose. The process involves transforming plant cells with the desired gene, allowing them to produce the therapeutic protein. After cultivation, the harvested plants or plant cells serve as biofactories for the production of pharmaceuticals. This approach has shown promise for producing vaccines, antibodies, and other biologics.
Plant-Based Biopharmaceuticals offer benefits such as rapid scalability, reduced production costs, and potentially safer and more accessible production facilities. Additionally, plant-based systems contribute to the development of sustainable and environmentally friendly biomanufacturing practices. As research in this field advances, Plant-Based Biopharmaceuticals hold significant potential to transform the landscape of pharmaceutical production.
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Exploring classical ayurvedic drugs in hypertension
Prashant Bhokardankar, Datta Meghe Ayurved College, India
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : A unique role and and impact of catalytic antibodies (abzymes) in clinical practice: A novel strategy for predicting and preventing relapse in chronic autoimmune conditions
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promising future of the unique translational tool to manage beta-cell population renewal and regeneration to secure the post-diabetic period
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Easily injectable, organic solvent free self assembled hydrogel platform for endoscope mediated gastrointestinal polypectomy
Hitasha Vithalani , IIT Gandhinagar, India